ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,Y
1,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
4,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4,2,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,Y
5,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
5,2,Vulvitis,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
6,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
6,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
7,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
8,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
8,2,Pruritus allergic,Pruritus NEC,Epidermal and dermal conditions,Skin,N
9,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
9,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
10,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
11,1,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
12,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
12,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
12,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
12,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
13,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
14,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
15,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
16,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
16,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
16,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
17,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
18,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
18,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
18,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
18,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
18,5,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
18,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
19,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
19,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
19,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
19,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
19,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
19,6,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
20,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
20,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
21,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
21,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
22,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,1,Blood parathyroid hormone increased,Parathyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
23,2,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
23,3,Blood urea decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
23,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
23,5,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
23,6,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
24,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
24,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
24,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
24,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
25,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
25,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
25,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
25,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
26,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
26,2,Negative thoughts,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
26,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
26,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
27,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
27,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
27,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
28,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
28,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
29,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
30,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
30,2,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
31,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
31,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
31,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
31,4,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
31,5,Headache,Headaches NEC,Headaches,Nerv,N
31,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
31,7,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
31,8,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
31,9,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
31,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
31,11,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
31,12,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
31,13,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
31,14,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
31,15,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
32,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
33,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
34,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
35,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
36,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
36,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
37,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
38,1,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
39,1,Orbital oedema,"Orbital structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
40,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
40,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
41,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
42,1,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
42,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
42,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
42,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
43,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
44,1,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
44,2,Eye oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
44,3,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
44,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
45,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,Y
46,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
46,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
46,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
46,4,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
46,5,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
46,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
47,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
48,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
48,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
49,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
49,2,Headache,Headaches NEC,Headaches,Nerv,N
49,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
49,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
50,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
50,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
50,3,Procedural pain,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
51,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
51,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
52,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
52,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
53,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
54,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
55,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
55,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
55,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
55,4,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
55,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
55,6,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
56,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
56,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
57,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
57,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
57,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
57,4,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
57,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
57,6,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
58,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
58,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
59,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
60,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
61,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
61,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
62,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
63,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
63,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
64,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
64,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
65,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
65,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
65,3,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
66,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
67,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
67,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
68,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
69,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
70,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
71,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
72,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
73,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
74,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
75,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
75,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
75,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
75,4,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
75,5,Headache,Headaches NEC,Headaches,Nerv,N
75,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
75,7,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
75,8,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
75,9,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
75,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
75,11,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
75,12,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
75,13,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
75,14,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
75,15,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
75,16,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
76,1,Hepatic mass,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
76,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
76,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
76,4,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
76,5,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
77,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
78,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
78,2,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
78,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
79,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
79,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
80,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
80,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
80,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
80,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
80,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
81,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
81,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
82,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
82,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
82,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
83,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
83,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
83,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
83,4,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
84,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
84,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
84,3,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
84,4,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
85,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
85,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
85,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
85,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
85,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
86,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
87,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
87,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
87,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
87,4,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
87,5,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
88,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
88,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
89,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
90,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
91,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
92,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
93,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
94,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
95,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
95,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
95,3,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
96,1,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
97,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
98,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
98,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
98,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
98,4,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
98,5,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
98,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
99,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
100,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
101,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
102,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
102,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
103,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
104,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
104,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
104,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
104,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
104,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
104,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
104,7,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
105,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
105,2,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
106,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
107,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
108,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
109,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
109,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
109,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
110,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
110,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
111,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
112,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
113,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
114,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
114,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
115,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
116,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
117,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
118,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
118,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
118,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
118,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
119,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
120,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
120,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
121,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
122,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
123,1,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
123,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
123,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
123,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
124,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
124,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
125,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
125,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
126,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
126,2,Pyloric stenosis,Gastric disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
127,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
127,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,Y
128,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
128,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
128,3,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
129,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
129,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
129,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
129,4,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
129,5,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
129,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
130,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
131,1,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
131,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
132,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
133,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
133,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
133,3,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
134,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
134,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
134,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
134,4,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
135,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
135,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
136,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
136,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
137,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
137,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
138,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
138,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
138,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
139,1,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
139,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
140,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
141,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
142,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
142,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
143,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
143,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
144,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
144,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
144,3,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
145,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
146,1,Recall phenomenon,Skin procedural complications,Procedural related injuries and complications NEC,Inj&P,N
147,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
148,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
148,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
149,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
149,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
149,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
149,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
150,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
151,1,Recall phenomenon,Skin procedural complications,Procedural related injuries and complications NEC,Inj&P,N
152,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
152,2,Nasal ulcer,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
152,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
152,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
153,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
153,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
153,3,Pyloric stenosis,Gastric disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
153,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
154,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
155,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
156,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
156,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
156,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
156,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
156,5,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
156,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
156,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
156,8,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
157,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
157,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
157,3,Platelet disorder,Platelet disorders NEC,Platelet disorders,Blood,N
157,4,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
157,5,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
158,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
158,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
158,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
159,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
159,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
160,1,Child-Pugh-Turcotte score abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
160,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
160,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
160,4,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
160,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
161,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
161,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
161,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
162,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
162,2,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
162,3,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
163,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
163,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
164,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
164,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
164,3,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
164,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
164,5,Pneumococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,N
164,6,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
165,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
166,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
166,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
167,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
168,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
168,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
169,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
170,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
171,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
172,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
173,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
173,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
174,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
175,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
175,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
176,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
177,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
177,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
177,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
178,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
179,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
180,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
181,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
182,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
183,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
183,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
184,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
185,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
186,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
187,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
187,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
187,3,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
188,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
188,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
188,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
188,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
189,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
190,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
190,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
190,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
190,4,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
190,5,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
191,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
191,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
192,1,Recall phenomenon,Skin procedural complications,Procedural related injuries and complications NEC,Inj&P,N
193,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
193,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
193,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
194,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
194,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
195,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
196,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
197,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
198,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
198,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
199,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
199,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
200,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
200,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
200,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
200,4,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
200,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
200,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
200,7,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
200,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
200,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
201,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
202,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
202,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
202,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
202,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
202,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
202,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
203,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
203,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
203,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
203,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
203,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
203,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
203,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
204,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
204,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
205,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
205,2,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
205,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
205,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
206,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
207,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
208,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
209,1,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
209,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
210,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
210,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
210,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
211,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
212,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
213,1,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
214,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
215,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
215,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
216,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
217,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
218,1,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
218,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
219,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
220,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
221,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
222,1,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
223,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
223,2,Sjogren's syndrome,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
223,3,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
224,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
224,2,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
224,3,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
225,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
225,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
225,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
225,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
225,5,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
225,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
226,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
226,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
226,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
227,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
228,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
228,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
228,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
229,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
229,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
229,3,Metastases to spinal cord,Metastases to specified sites,Metastases,Neopl,N
229,4,PIK3CA-activated mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
229,5,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
229,6,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
230,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
231,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
231,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
231,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
231,4,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
231,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
231,6,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
231,7,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
231,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
231,9,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
232,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
233,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
233,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
233,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
234,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
235,1,Lichen planus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
235,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
235,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
236,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
236,2,Urinary tract obstruction,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
237,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
238,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
239,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
240,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
240,2,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
240,3,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
241,1,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
241,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
241,3,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
242,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
242,2,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
242,3,Retroperitoneal fibrosis,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
242,4,Ureteric obstruction,Ureteric disorders NEC,Ureteric disorders,Renal,N
243,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
243,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
243,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
244,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
245,1,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
245,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
245,3,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
245,4,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
246,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
246,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
247,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
247,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
247,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
248,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
248,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
248,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
249,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
250,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
250,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
250,3,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
250,4,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
251,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
252,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
252,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
252,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
252,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
253,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
253,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
253,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
254,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
254,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
254,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
254,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
254,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
255,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
255,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
255,3,Lymphocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
255,4,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
256,1,Blood bilirubin abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
256,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
256,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
257,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
257,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
258,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
258,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
258,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
259,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,Y
259,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
260,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
260,2,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
260,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
261,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
261,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
262,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
262,2,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,Y
262,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
263,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
263,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
264,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
264,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
264,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
264,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
264,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
265,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
265,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
265,3,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
265,4,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
266,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
266,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
266,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
266,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
267,1,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
268,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
268,2,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
269,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
269,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
269,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
269,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
269,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
269,6,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
270,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
271,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
271,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
272,1,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
273,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
274,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
274,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
275,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
276,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
276,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
276,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
277,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
278,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
279,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
279,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
279,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
279,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
279,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
279,6,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
280,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
280,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
280,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
281,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
281,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
281,3,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
281,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
281,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
282,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
282,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
283,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
283,2,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
283,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
283,4,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
284,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
284,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
284,3,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
284,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
284,5,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
284,6,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
285,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
286,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
286,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
287,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
287,2,Duodenal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
287,3,Invasive lobular breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
287,4,PIK3CA-activated mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
287,5,Peritoneal disorder,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
287,6,Rectosigmoid cancer recurrent,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
288,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,Y
289,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
289,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
290,1,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
291,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
292,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
293,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
293,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
294,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
295,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
295,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
295,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
295,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
295,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
295,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
295,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
296,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
296,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
296,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
296,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
296,5,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
296,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
296,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
297,1,Alanine aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
297,2,Cancer fatigue,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
298,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
299,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
299,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
299,3,Lymphangitis,Vascular infections,Infections - pathogen unspecified,Infec,N
299,4,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
299,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
300,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
300,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
301,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
301,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
301,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
302,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
302,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
302,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
303,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
304,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
305,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
305,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
306,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
306,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
306,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
307,1,Cervix cancer metastatic,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
307,2,Cervix haemorrhage uterine,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
307,3,Endometrial cancer metastatic,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
307,4,Invasive lobular breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
307,5,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
307,6,Metastases to gastrointestinal tract,Metastases to specified sites,Metastases,Neopl,N
307,7,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
307,8,Metastases to ovary,Metastases to specified sites,Metastases,Neopl,N
307,9,Metastases to retroperitoneum,Metastases to specified sites,Metastases,Neopl,N
308,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
308,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
308,3,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
308,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
308,5,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
308,6,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
308,7,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
308,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
308,9,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
308,10,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
308,11,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
308,12,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
308,13,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
308,14,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
309,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
309,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
309,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
309,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
309,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
309,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
310,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
311,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
312,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
313,1,Endometrial adenocarcinoma,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
313,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
313,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
313,4,Pseudocirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
313,5,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
314,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
314,2,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
314,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
314,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
314,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
314,6,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
314,7,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
315,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
316,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
316,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
317,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
317,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
317,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
317,4,Vitamin D decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
318,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
319,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
320,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
321,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
322,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
323,1,Headache,Headaches NEC,Headaches,Nerv,N
324,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
325,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
326,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
327,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
327,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
327,3,Headache,Headaches NEC,Headaches,Nerv,N
328,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
328,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
329,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
329,2,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
330,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
331,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
332,1,Headache,Headaches NEC,Headaches,Nerv,N
332,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
332,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
333,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
334,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
335,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
336,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
337,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
337,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
338,1,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
339,1,Tumour marker increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
340,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
340,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
340,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
340,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
340,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
340,6,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
340,7,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
340,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
341,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
342,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
342,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
343,1,Tumour marker increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
344,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
345,1,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
346,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
347,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
348,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
349,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
350,1,Headache,Headaches NEC,Headaches,Nerv,N
351,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
351,2,Headache,Headaches NEC,Headaches,Nerv,N
351,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
352,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
352,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
353,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
353,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
354,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
355,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
356,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
357,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
358,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
358,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
359,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
359,2,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
360,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
360,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
360,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
360,4,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
360,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
360,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
361,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
361,2,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
362,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
363,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
363,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
363,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
363,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
364,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
364,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
364,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
365,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
365,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
365,3,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
365,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
366,1,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
366,2,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
366,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
367,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
368,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
368,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
369,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
369,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
370,1,Chapped lips,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
371,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
372,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
372,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
373,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
373,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
374,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
374,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
374,3,Shoulder fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
375,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
375,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
376,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
376,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
376,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
376,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
376,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
376,6,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
377,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
377,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
377,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
378,1,Abdominal adhesions,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
378,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
378,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
378,4,Gastrointestinal sounds abnormal,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
378,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
379,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
380,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
380,2,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
380,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
380,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
381,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
382,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
383,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
384,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
385,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
386,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
386,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
387,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
388,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
389,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
389,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
389,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
390,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
391,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
391,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
391,3,Headache,Headaches NEC,Headaches,Nerv,N
391,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
392,1,Chapped lips,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
392,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
392,3,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
393,1,Cancer fatigue,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
394,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
394,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
395,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
396,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
396,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
397,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
397,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
397,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
398,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
399,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
399,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
399,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
399,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
399,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
400,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
401,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
402,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
403,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
404,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
405,1,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
405,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
405,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
405,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
405,5,Reflux gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
405,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
406,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
407,1,Obliterative bronchiolitis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
408,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
409,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
410,1,Corneal pigmentation,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
411,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
412,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
412,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
413,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
413,2,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
414,1,Oral mucosa erosion,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
415,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
416,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
416,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
416,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
416,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
416,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
417,1,Adnexa uteri mass,Pelvis and broad ligament disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
417,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
417,3,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
417,4,Small intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
417,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
418,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
418,2,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
418,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
418,4,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
419,1,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
420,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
420,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
420,3,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
420,4,Wound haemorrhage,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
421,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
422,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
422,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
422,3,Drug tolerance decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
422,4,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
422,5,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
422,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
422,7,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
422,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
422,9,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
422,10,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
422,11,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
422,12,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
422,13,Mucosal toxicity,Mucosal findings abnormal,General system disorders NEC,Genrl,N
422,14,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
422,15,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
422,16,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
423,1,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
424,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
425,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
425,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
425,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
426,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
426,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
427,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
427,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
428,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
429,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
430,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
430,2,Atelectasis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
430,3,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
430,4,Diverticulum intestinal,Diverticula,Diverticular disorders,Gastr,N
430,5,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
430,6,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
430,7,Infected cyst,Infections NEC,Infections - pathogen unspecified,Infec,N
430,8,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
430,9,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
430,10,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
430,11,Pathological fracture,Fractures NEC,Fractures,Musc,N
430,12,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
430,13,Renal cyst,Renal neoplasms,Renal disorders (excl nephropathies),Renal,N
431,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
432,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
433,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
434,1,Laboratory test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
434,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
435,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
435,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
436,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
437,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
437,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
438,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
438,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
439,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
440,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
441,1,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
441,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
441,3,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
442,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
442,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
442,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
443,1,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
444,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
444,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
444,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
444,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
445,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
445,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
445,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
446,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
447,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
447,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
447,3,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
447,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
448,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
449,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
450,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
450,2,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
451,1,Vein collapse,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
451,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
452,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
453,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
454,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
454,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
455,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
456,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
456,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
457,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
457,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
458,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
459,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
460,1,Migraine with aura,Migraine headaches,Headaches,Nerv,N
461,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
462,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
463,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
464,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
465,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
465,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
466,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
467,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
468,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
468,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
469,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
470,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
471,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
471,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
471,3,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
472,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
472,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
473,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
474,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
475,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
476,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
476,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
476,3,Pulmonary valve stenosis,Pulmonary valvular disorders,Cardiac valve disorders,Card,N
476,4,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
477,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
478,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
478,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
478,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
479,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
480,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
480,2,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
481,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
482,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
483,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
484,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
485,1,Creatinine renal clearance increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
486,1,Creatinine renal clearance increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
487,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
488,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
489,1,Carbohydrate antigen 15-3 increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
489,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
489,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
490,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
490,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
490,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
491,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
491,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
491,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
491,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
491,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
491,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
491,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
491,8,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
491,9,Headache,Headaches NEC,Headaches,Nerv,N
491,10,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
491,11,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
491,12,Metastases to chest wall,Metastases to specified sites,Metastases,Neopl,N
491,13,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
491,14,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
491,15,Metastases to pancreas,Metastases to specified sites,Metastases,Neopl,N
491,16,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
491,17,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
491,18,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
491,19,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
491,20,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
491,21,Tumour marker increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
492,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
492,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
493,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
494,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
494,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
495,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
496,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
497,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
498,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
499,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
500,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
501,1,Acute cardiac event,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,Y
502,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
503,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
503,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
504,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
504,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
504,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
505,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
505,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
506,1,Nitrogen balance negative,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
507,1,Alopecia totalis,Alopecias,Skin appendage conditions,Skin,N
508,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
509,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
510,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
510,2,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
511,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
511,2,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
512,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
513,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
514,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
515,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
515,2,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
516,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
516,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
517,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
518,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
518,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
518,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
518,4,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
519,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
519,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
520,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
521,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
521,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
522,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
522,2,Carbohydrate antigen 15-3 increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
522,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
523,1,Eye operation,Eye therapeutic procedures NEC,Eye therapeutic procedures,Surg,N
524,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
525,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
526,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
526,2,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
527,1,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
528,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
529,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
530,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
530,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
531,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
531,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
532,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
533,1,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
534,1,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
535,1,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
536,1,White blood cell disorder,White blood cell abnormal findings NEC,White blood cell disorders,Blood,N
537,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
538,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
539,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
540,1,Hip surgery,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
541,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
541,2,Nerve compression,Mononeuropathies,Peripheral neuropathies,Nerv,N
542,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
542,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
543,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
544,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
545,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
545,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
545,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
545,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
546,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
547,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
548,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
549,1,Lichen sclerosus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
550,1,Lichen sclerosus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
551,1,Lichen sclerosus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
552,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
553,1,Lichen sclerosus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
554,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
555,1,Lichen sclerosus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
556,1,Lichen sclerosus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
557,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
557,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
557,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
557,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
557,5,Headache,Headaches NEC,Headaches,Nerv,N
557,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
557,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
558,1,Lichen sclerosus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
559,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
560,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
561,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
561,2,Oophorectomy bilateral,Ovarian therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
561,3,PIK3CA-activated mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
561,4,Peritoneal disorder,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
561,5,Peritoneal lesion,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
561,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
562,1,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
562,2,Lichen sclerosus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
562,3,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
562,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
562,5,Skin hypopigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
562,6,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
563,1,Lichen sclerosus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
564,1,Cardiac ventricular thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,Y
565,1,Lichen sclerosus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
566,1,Lichen sclerosus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
567,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
568,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
568,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
568,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
569,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
570,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
571,1,Lichen sclerosus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
572,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
573,1,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
574,1,Bone prosthesis insertion,Bone therapeutic procedures NEC,Bone and joint therapeutic procedures,Surg,N
575,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
576,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
577,1,Ear operation,"Head, neck and oral cavity therapeutic procedures NEC",Head and neck therapeutic procedures,Surg,N
578,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
578,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
578,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
578,4,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
578,5,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
579,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
580,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
581,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
581,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
582,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
583,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
584,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
585,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
586,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
587,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
588,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
588,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
589,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
590,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
591,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
592,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
592,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
593,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
593,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
593,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
594,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
594,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
594,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
594,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
595,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
595,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
596,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
597,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
598,1,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
599,1,Endodontic procedure,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
600,1,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
601,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
601,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
601,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
602,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
603,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
604,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
605,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
606,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
606,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
607,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
608,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
609,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
609,2,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
610,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
611,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
611,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
611,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
611,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
611,5,Internal fixation of fracture,Fracture treatments (excl skull and spine),Bone and joint therapeutic procedures,Surg,N
611,6,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
611,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
611,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
611,9,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
612,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
612,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
613,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
614,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
614,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
614,3,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
614,4,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
614,5,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
615,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
615,2,Dental operation,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
616,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
616,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
617,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
618,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
619,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
620,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
